Background There is considerable variability in COVID-19 outcomes among younger adults,
and some of this variation may be due to genetic predisposition. Methods We combined …

Background A high proportion of COVID‐19 patients have cardiac involvement, even those
without known cardiac disease. Downregulation of angiotensin converting enzyme 2 (ACE2), …

In SARS-CoV-2 infection there is an urgent need to identify patients that will progress to
severe COVID-19 and may benefit from targeted treatment. In this study we analyzed plasma …

Objectives To determine the incidence and characteristics of superinfections in mechanically
ventilated COVID-19 patients, and the impact of dexamethasone as standard therapy. …

Given the highly variable clinical phenotype of Coronavirus disease 2019 (COVID-19), a
deeper analysis of the host genetic contribution to severe COVID-19 is important to improve our …

Introduction Very little is known about possible clinical sequelae that may persist after
resolution of acute COVID-19. A recent longitudinal cohort from Italy including 143 patients …

Objective To test the hypotheses that blood biomarkers for nervous system injury, serum
concentrations of neurofilament light chain protein (NfL) and glial fibrillary acidic protein (GFAp) …

Diagnostic assays currently used to monitor the efficacy of COVID-19 vaccines measure levels
of antibodies to the receptor-binding domain of ancestral SARS-CoV-2 (RBDwt). However…

Background Gut microbiota alterations have been reported in hospitalized COVID-19 patients,
with reduced alpha diversity and altered microbiota composition related to respiratory …

Background Immune dysregulation is a major factor in the development of severe coronavirus
disease 2019 (COVID-19). The homeostatic chemokines CCL19 and CCL21 have been …